Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation

NAActive, not recruitingINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2025

Conditions
Chronic Stroke
Interventions
DEVICE

MR-001

MR-001 is an autonomous neurorehabilitation system based on the principles of Rhythmic Auditory Stimulation intended to improve walking and ambulation in adult chronic stroke patients. MR-001 is intended to be a prescription use only device for use at home/community. The user operates the MR-001 System autonomously and the therapy progresses automatically once a user engages in a session. The MR-001 system consists of two foot sensors that measure walking, a touchscreen device preloaded solely with a proprietary software application, a headset, and charging equipment. The electronic components are powered by lithium-ion rechargeable batteries. Participants are asked to walk with the device for 3 times per week for 12 weeks. Each walking session is 30 minutes in length.

Trial Locations (1)

04101

Curavit Clinical Research - DECENTRALIZED CLINICAL TRIAL, Portland

All Listed Sponsors
lead

MedRhythms, Inc.

INDUSTRY

NCT06051539 - Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation | Biotech Hunter | Biotech Hunter